These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30633973)

  • 1. Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistance.
    Pan J; Mendes LP; Yao M; Filipczak N; Garai S; Thakur GA; Sarisozen C; Torchilin VP
    Eur J Pharm Biopharm; 2019 Mar; 136():18-28. PubMed ID: 30633973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
    Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charge reversible hyaluronic acid-modified dendrimer-based nanoparticles for siMDR-1 and doxorubicin co-delivery.
    Zhang X; Pan J; Yao M; Palmerston Mendes L; Sarisozen C; Mao S; Torchilin VP
    Eur J Pharm Biopharm; 2020 Sep; 154():43-49. PubMed ID: 32645383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the surface charge of polyamidoamine dendrimers on cellular exocytosis and the exocytosis mechanism in multidrug-resistant breast cancer cells.
    Zhang J; Li M; Wang M; Xu H; Wang Z; Li Y; Ding B; Gao J
    J Nanobiotechnology; 2021 May; 19(1):135. PubMed ID: 33980270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemosensitization of doxorubicin in multidrug-resistant cells by unimolecular micelles via increased cellular accumulation and apoptosis.
    Wang M; Han M; Li Y; Jin Y; Gao JQ
    J Pharm Pharmacol; 2016 Mar; 68(3):333-41. PubMed ID: 26893058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pluronic-attached polyamidoamine dendrimer conjugates overcome drug resistance in breast cancer.
    Wang M; Li Y; HuangFu M; Xiao Y; Zhang T; Han M; Xu D; Li F; Ling D; Jin Y; Gao J
    Nanomedicine (Lond); 2016 Nov; 11(22):2917-2934. PubMed ID: 27780403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of multidrug resistance in breast cancer MCF-7/ADR cells by h-R3-siMDR1-PAMAM complexes.
    Li J; Liu J; Guo N; Zhang X
    Int J Pharm; 2016 Sep; 511(1):436-445. PubMed ID: 27444552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulated cellular delivery of anti-VEGF siRNA (bevasiranib) by incorporating supramolecular assemblies of hydrophobically modified polyamidoamine dendrimer in stealth liposomes.
    Golkar N; Samani SM; Tamaddon AM
    Int J Pharm; 2016 Aug; 510(1):30-41. PubMed ID: 27291973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional polyamidoamine-modified selenium nanoparticles dual-delivering siRNA and cisplatin to A549/DDP cells for reversal multidrug resistance.
    Zheng W; Cao C; Liu Y; Yu Q; Zheng C; Sun D; Ren X; Liu J
    Acta Biomater; 2015 Jan; 11():368-80. PubMed ID: 25204523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive polymer micelle designed for siRNA delivery and reversal of MDR1 gene-dependent multidrug resistance.
    Zhang CG; Yang SD; Zhu WJ; You BG; Liu Y; Yuan ZQ; Chen WL; Li JZ; Zhou XF; Liu C; Zhang XN
    J Biomed Mater Res B Appl Biomater; 2017 Oct; 105(7):2093-2106. PubMed ID: 27405391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
    Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W
    J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of chemosensitivity by multifunctional micelles mediated by P-gp siRNA to reverse MDR.
    Shen J; Wang Q; Hu Q; Li Y; Tang G; Chu PK
    Biomaterials; 2014 Oct; 35(30):8621-34. PubMed ID: 25002258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-Delivery of siRNA and Chemotherapeutic Drug Using 2C5 Antibody-Targeted Dendrimer-Based Mixed Micelles for Multidrug Resistant Cancers.
    Yalamarty SSK; Filipczak N; Li X; Pathrikar TV; Cotter C; Torchilin VP
    Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex.
    Han M; Lv Q; Tang XJ; Hu YL; Xu DH; Li FZ; Liang WQ; Gao JQ
    J Control Release; 2012 Oct; 163(2):136-44. PubMed ID: 22940126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionalized graphene oxide mediated adriamycin delivery and miR-21 gene silencing to overcome tumor multidrug resistance in vitro.
    Zhi F; Dong H; Jia X; Guo W; Lu H; Yang Y; Ju H; Zhang X; Hu Y
    PLoS One; 2013; 8(3):e60034. PubMed ID: 23527297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro studies of phospholipid-modified PAMAM-siMDR1 complexes for the reversal of multidrug resistance in human breast cancer cells.
    Liu J; Li J; Liu N; Guo N; Gao C; Hao Y; Chen L; Zhang X
    Int J Pharm; 2017 Sep; 530(1-2):291-299. PubMed ID: 28619457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
    Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy.
    Li J; Liang H; Liu J; Wang Z
    Int J Pharm; 2018 Jul; 546(1-2):215-225. PubMed ID: 29787895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of dual drug-loaded dendrimer/carbon dot nanohybrids for fluorescence imaging and enhanced chemotherapy of cancer cells.
    Li D; Fan Y; Shen M; Bányai I; Shi X
    J Mater Chem B; 2019 Jan; 7(2):277-285. PubMed ID: 32254552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.